| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Mu-type opioid receptor |
|---|
| Ligand | BDBM438841 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Competitive Displacement Assay |
|---|
| Ki | <1±n/a nM |
|---|
| Citation |  Wynn, TA; Alvarez, JC; Moustakas, DT; Haeberlein, M; Pennington, LD Compounds for the treatment of pain US Patent US10604489 Publication Date 3/31/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Mu-type opioid receptor |
|---|
| Name: | Mu-type opioid receptor |
|---|
| Synonyms: | M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1 |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 44789.51 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P35372 |
|---|
| Residue: | 400 |
|---|
| Sequence: | MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCP
PTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALAT
STLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDF
RTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFI
FAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHI
YVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNI
EQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
|
|
|
|---|
| BDBM438841 |
|---|
| n/a |
|---|
| Name | BDBM438841 |
|---|
| Synonyms: | 3-((1R,5S,9r)-9-methoxy-3-(7-oxaspiro[3.5]nonan-2-yl)-3-azabicyclo[3.3.1]nonan-9-yl)benzamide hydrochloride | US10604489, Compound 6 | US11180455, Compound 6 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C24H34N2O3 |
|---|
| Mol. Mass. | 398.5384 |
|---|
| SMILES | COC1(C2CCCC1CN(C2)C1CC2(C1)CCOCC2)c1cccc(c1)C(N)=O |TLB:11:9:2:5.4.6,20:2:5.4.6:8.10.9,THB:1:2:5.4.6:8.10.9| |
|---|
| Structure | 
|
|---|
Search and Browse
